MCRFX | VMVAX | MCRFX / VMVAX | |
Total Expense Ratio | 1.75 | 0.07 | 2,500% |
Annual Report Gross Expense Ratio | 1.89 | 0.07 | 2,700% |
Fund Existence | 31 years | 14 years | - |
Gain YTD | 5.032 | 5.198 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 964M | 31B | 3% |
Annual Yield % from dividends | 1.58 | 2.22 | 71% |
Returns for 1 year | -2.47 | 7.67 | -32% |
Returns for 3 years | 3.75 | 17.51 | 21% |
Returns for 5 years | 27.69 | 65.15 | 43% |
Returns for 10 years | -8.92 | 87.87 | -10% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EDIV | 39.06 | 0.14 | +0.36% |
SPDR® S&P Emerging Markets Dividend ETF | |||
FCEF | 22.61 | 0.04 | +0.16% |
First Trust Income Opportunity ETF | |||
GDIV | 15.76 | N/A | +0.02% |
Harbor Dividend Growth Leaders ETF | |||
RND | 28.10 | -0.06 | -0.20% |
First Trust Bloomberg R&D Leaders ETF | |||
VV | 297.02 | -0.64 | -0.22% |
Vanguard Large-Cap ETF |